DexCom, Inc. (BVMF:D1EX34)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of BRL 145.01 billion. The enterprise value is 141.92 billion.

Market Cap	145.01B
Enterprise Value	141.92B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.09%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	97.09%
Float	383.05M

Valuation Ratios

The trailing PE ratio is 31.48 and the forward PE ratio is 28.81.

PE Ratio	31.48
Forward PE	28.81
PS Ratio	5.65
PB Ratio	9.59
P/TBV Ratio	9.93
P/FCF Ratio	24.44
P/OCF Ratio	18.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.08, with an EV/FCF ratio of 23.92.

EV / Earnings	30.81
EV / Sales	5.93
EV / EBITDA	23.08
EV / EBIT	30.33
EV / FCF	23.92

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.51.

Current Ratio	1.88
Quick Ratio	1.53
Debt / Equity	0.51
Debt / EBITDA	1.17
Debt / FCF	1.30
Interest Coverage	49.83

Financial Efficiency

Return on equity (ROE) is 34.50% and return on invested capital (ROIC) is 33.98%.

Return on Equity (ROE)	34.50%
Return on Assets (ROA)	8.89%
Return on Invested Capital (ROIC)	33.98%
Return on Capital Employed (ROCE)	21.72%
Weighted Average Cost of Capital (WACC)	11.86%
Revenue Per Employee	2.32M
Profits Per Employee	416,863
Employee Count	11,050
Asset Turnover	0.73
Inventory Turnover	3.18

Taxes

In the past 12 months, DexCom has paid 1.39 billion in taxes.

Income Tax	1.39B
Effective Tax Rate	23.16%

Stock Price Statistics

The stock price has decreased by -25.12% in the last 52 weeks. The beta is 1.49, so DexCom's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-25.12%
50-Day Moving Average	7.38
200-Day Moving Average	8.06
Relative Strength Index (RSI)	54.84
Average Volume (20 Days)	3,909

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.81

Income Statement

In the last 12 months, DexCom had revenue of BRL 25.68 billion and earned 4.61 billion in profits. Earnings per share was 11.51.

Revenue	25.68B
Gross Profit	15.43B
Operating Income	5.02B
Pretax Income	5.99B
Net Income	4.61B
EBITDA	6.41B
EBIT	5.02B
Earnings Per Share (EPS)	11.51

Balance Sheet

The company has 11.01 billion in cash and 7.69 billion in debt, with a net cash position of 3.32 billion.

Cash & Cash Equivalents	11.01B
Total Debt	7.69B
Net Cash	3.32B
Net Cash Per Share	n/a
Equity (Book Value)	15.12B
Book Value Per Share	39.31
Working Capital	10.41B

Cash Flow

In the last 12 months, operating cash flow was 7.94 billion and capital expenditures -2.00 billion, giving a free cash flow of 5.93 billion.

Operating Cash Flow	7.94B
Capital Expenditures	-2.00B
Free Cash Flow	5.93B
FCF Per Share	n/a

Margins

Gross margin is 60.10%, with operating and profit margins of 19.56% and 17.94%.

Gross Margin	60.10%
Operating Margin	19.56%
Pretax Margin	23.35%
Profit Margin	17.94%
EBITDA Margin	24.96%
EBIT Margin	19.56%
FCF Margin	23.11%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.75%
Shareholder Yield	1.75%
Earnings Yield	3.18%
FCF Yield	4.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 7.06 and a Piotroski F-Score of 6.

Altman Z-Score	7.06
Piotroski F-Score	6